Cart
sales@molnova.com
cFMS Receptor Inhibitor IV
CAS No. 959626-45-0
cFMS Receptor Inhibitor IV( 5-cyano-N-(2,5-di(piperidin-1-yl)phenyl)furan-2-carboxamide )
Catalog No. M28536 CAS No. 959626-45-0
cFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 177 | Get Quote |
|
| 10MG | 282 | Get Quote |
|
| 25MG | 480 | Get Quote |
|
| 50MG | 691 | Get Quote |
|
| 100MG | 972 | Get Quote |
|
| 500MG | 1944 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamecFMS Receptor Inhibitor IV
-
NoteResearch use only, not for human use.
-
Brief DescriptioncFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.
-
DescriptioncFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.
-
In Vitro——
-
In Vivo——
-
Synonyms5-cyano-N-(2,5-di(piperidin-1-yl)phenyl)furan-2-carboxamide
-
PathwayTyrosine Kinase
-
TargetCSF1R
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number959626-45-0
-
Formula Weight378.47
-
Molecular FormulaC22H26N4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 31.25 mg/mL (82.57 mM)
-
SMILESN#CC=1OC(=CC1)C(=O)NC2=CC(=CC=C2N3CCCCC3)N4CCCCC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Vimseltinib
DCC-3014 is a c-FMS (CSF-IR) and c-Kit dual inhibitor (IC50s: <0.01 μM and 0.1-1 μM) extracted from the patent WO2014145025A2 (Example 10).
-
ARRY-382
ARRY-382 is a highly selective oral inhibitor of CSF-1R with an IC50 of 9 nM.
-
Pimicotinib
Pimicotinib (ABSK021) is a potent CSF1R inhibitor with antitumor activity and can be used to study advanced solid tumors.
